Helus Pharma (HELP) vs Lexicon Pharmaceuticals (LXRX)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 7, 2026.
Summary
Helus Pharma (HELP) has outperformed Lexicon Pharmaceuticals (LXRX) over the past year, gaining 73.1% versus a gain of 15.8%. Over five years, LXRX leads with a -71.4% price change compared with -86.0% for HELP. Lexicon Pharmaceuticals is the larger company by market cap ($783.1 million vs $767.9 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | HELP | LXRX |
|---|---|---|
| Share price | $10.51 | $1.76 |
| Market cap | $767.86M | $783.12M |
| 1-day change | -2.32% | +0.57% |
| YTD return | +28.48% | +53.04% |
| 1-year return | +73.15% | +15.79% |
| 5-year return | -85.96% | -71.43% |
| EPS (TTM) | $-4.15 | $-0.16 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $15.15 | $2.68 |
| 52-week low | $3.76 | $1.10 |
| Distance from 52-week high | -30.63% | -34.33% |
| Average volume | 1.79M | 2.91M |
| Shares outstanding | 73.06M | 444.96M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- HELP has outperformed LXRX by 57.4 percentage points over the past year.
HELP vs LXRX FAQ
Which is bigger, Helus Pharma or Lexicon Pharmaceuticals?
Lexicon Pharmaceuticals (LXRX) is larger, with a market capitalization of $783.12M compared with $767.86M for Helus Pharma (HELP).
Which stock has performed better over the past year, HELP or LXRX?
HELP returned +73.15% over the past 12 months, compared with +15.79% for LXRX (price return, excluding dividends). Past performance does not predict future results.
Are Helus Pharma and Lexicon Pharmaceuticals in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.